Ondine Biopharma Corporation Announces Positive Clinical Results From its Periowave(TM) Trial Of Maintenance Therapy

VANCOUVER, Jan. 22 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) today announced that the publication of three Periowave(TM) clinical trial abstracts will be presented at the combined meetings of the International Association for Dental Research (IADR) and the American Association for Dental Research (AADR) meeting in New Orleans, March 21-24, 2007. The IADR/AADR meeting is expected to attract 5000 dental researchers from around the world who are dedicated to the prevention and treatment of oral and dental diseases.
MORE ON THIS TOPIC